Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India · Delayed Price · Currency is INR 520.60
+6.00 (1.17%)
Nov 9, 2026, 12:30 PM IST
Dr. Agarwal's Health Care Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,008 | 905.5 | 1,004 | 1,118 | 1,270 | 996.21 |
Short-Term Investments | 706.8 | 506.7 | 1,505 | 349.6 | 336.6 | - |
Trading Asset Securities | - | 1,425 | 2,637 | 4,356 | - | - |
Cash & Short-Term Investments | 1,714 | 2,838 | 5,147 | 5,823 | 1,606 | 996.21 |
Cash Growth | -56.78% | -44.86% | -11.62% | 262.47% | 61.25% | 80.43% |
Accounts Receivable | 1,870 | 1,609 | 1,236 | 968.1 | 763.3 | 567.15 |
Other Receivables | - | 110.2 | 517 | 33.8 | 33.51 | 77.71 |
Receivables | 1,870 | 1,719 | 1,753 | 1,002 | 796.81 | 644.86 |
Inventory | 1,084 | 940.3 | 802.7 | 519 | 360.36 | 329.18 |
Prepaid Expenses | - | 89 | 48 | 40.8 | 57.31 | 31.42 |
Restricted Cash | - | 6 | 0.7 | - | 3.1 | 5 |
Other Current Assets | 557.5 | 137.5 | 135.5 | 201.3 | 277.77 | 268.15 |
Total Current Assets | 5,226 | 5,730 | 7,886 | 7,586 | 3,102 | 2,275 |
Property, Plant & Equipment | 22,071 | 19,609 | 14,843 | 11,347 | 9,010 | 5,431 |
Long-Term Investments | - | 672.4 | 151.3 | - | - | - |
Goodwill | 7,676 | 7,358 | 7,348 | 4,620 | 2,732 | 1,481 |
Other Intangible Assets | 4,379 | 4,171 | 4,573 | 2,678 | 2,181 | 348.05 |
Long-Term Deferred Tax Assets | 319.8 | 268.9 | 319.7 | 366.9 | 554.57 | 141.49 |
Long-Term Deferred Charges | - | - | - | - | - | 39.5 |
Other Long-Term Assets | 2,402 | 1,608 | 1,594 | 931 | 671.55 | 546.08 |
Total Assets | 42,072 | 39,418 | 36,716 | 27,528 | 18,252 | 10,261 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,720 | 1,493 | 1,270 | 1,330 | 1,013 | 890.87 |
Accrued Expenses | - | 411.8 | 339.9 | 67.5 | 54.45 | 36.58 |
Short-Term Debt | - | - | - | 150 | 45.43 | 101.67 |
Current Portion of Long-Term Debt | 448.5 | 239.7 | 895.8 | 631.7 | 460.33 | 261.3 |
Current Portion of Leases | 984.5 | 908 | 638.3 | 528.8 | 450.73 | 267.59 |
Current Income Taxes Payable | 108.5 | 228 | 149.2 | 158.6 | 43.32 | 100.65 |
Current Unearned Revenue | - | 123.2 | 77.3 | 85.5 | 50.22 | 52.25 |
Other Current Liabilities | 1,820 | 1,212 | 1,408 | 1,046 | 895.71 | 349.12 |
Total Current Liabilities | 5,081 | 4,615 | 4,778 | 3,998 | 3,013 | 2,060 |
Long-Term Debt | 1,558 | 1,333 | 1,573 | 3,097 | 3,056 | 2,539 |
Long-Term Leases | 8,827 | 8,181 | 6,502 | 5,258 | 4,561 | 3,164 |
Pension & Post-Retirement Benefits | - | 164.9 | 125.5 | 94.2 | 64.9 | 43.1 |
Long-Term Deferred Tax Liabilities | - | 6.4 | 69.6 | 15.2 | 24.53 | 12.8 |
Other Long-Term Liabilities | 4,245 | 3,920 | 4,400 | 1,271 | 941.48 | 104.59 |
Total Liabilities | 19,711 | 18,221 | 17,448 | 13,733 | 11,661 | 7,923 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 317 | 316.8 | 315.9 | 93.3 | 79.26 | 68.6 |
Additional Paid-In Capital | - | 20,678 | 20,512 | 13,925 | 7,561 | 4,272 |
Retained Earnings | - | -622.5 | -1,842 | -266.6 | -1,035 | -1,910 |
Comprehensive Income & Other | 22,057 | -118.1 | -320.6 | -357.8 | -309.63 | -307.16 |
Total Common Equity | 22,374 | 20,255 | 18,666 | 13,394 | 6,296 | 2,124 |
Minority Interest | -12.7 | 942.4 | 602.3 | 401 | 295.14 | 214.44 |
Shareholders' Equity | 22,361 | 21,197 | 19,268 | 13,795 | 6,591 | 2,338 |
Total Liabilities & Equity | 42,072 | 39,418 | 36,716 | 27,528 | 18,252 | 10,261 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 11,818 | 10,662 | 9,609 | 9,665 | 8,573 | 6,333 |
Net Cash (Debt) | -10,103 | -7,824 | -4,463 | -3,843 | -6,967 | -5,337 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -31.60 | -24.58 | -14.88 | -14.49 | -29.55 | -25.93 |
Filing Date Shares Outstanding | 331.76 | 316.81 | 315.88 | 307.56 | 237.78 | 205.8 |
Total Common Shares Outstanding | 331.76 | 316.81 | 315.88 | 279.88 | 237.78 | 205.8 |
Working Capital | 144.4 | 1,115 | 3,108 | 3,588 | 88.61 | 214.79 |
Book Value Per Share | 67.44 | 63.93 | 59.09 | 47.86 | 26.48 | 10.32 |
Tangible Book Value | 10,320 | 8,726 | 6,745 | 6,097 | 1,382 | 295.18 |
Tangible Book Value Per Share | 31.11 | 27.54 | 21.35 | 21.78 | 5.81 | 1.43 |
Buildings | - | 116.3 | 115.9 | 114.5 | 86.71 | 86.71 |
Machinery | - | 9,628 | 7,429 | 5,471 | 4,248 | 3,117 |
Construction In Progress | - | 2,344 | 1,439 | 1,140 | 976.1 | 284.33 |
Leasehold Improvements | - | 4,926 | 3,670 | 2,659 | 1,779 | 1,208 |